Strides Arcolab to split operations into three
Strides Arcolab, an Indian global pharmaceutical company with headquarters in Bangalore, is to divide its operations into three separate units.
Strides Arcolab, an Indian global pharmaceutical company with headquarters in Bangalore, is to divide its operations into three separate units.
The speciality pharmaceuticals business is to be hived off into a wholly owned subsidiary called Strides Specialties. The pharmaceuticals operation will continue as Strides Arcolab, while the r&d business will become a wholly owned subsidiary called Strides Technology and Research.
Arun Kumar, group chief executive, said: "The reorganisation of the business is a major step to attain greater efficiency and accountable customer focused business units, while still retaining the aggressive and entrepreneurial spirit of Strides. Both our business units will be backed by a strong and independent r&d function."
Kumar expects the reorganisation to ensure aggressive growth, anchored by specific business strategies and led by an experienced pool of people.
Strides manufactures pharmaceutical formulations in various dosage forms, including sterile injectables with dedicated facilities for penicillin and penems, cephalosporins, oncolytics and lyophilised injectable products.
The company also produces pharmaceutical formulations in oral dosage forms, including capsules and tablets and softgel capsules.
